Trials / Completed
CompletedNCT02335827
Irreversible Electroporation(IRE) For Unresectable Renal Tumors
Irreversible Electroporation (IRE) for Unresectable Renal Tumors: Phase I and Phase II Clinical Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 15 (estimated)
- Sponsor
- Fuda Cancer Hospital, Guangzhou · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to investigate the safety and efficacy of irreversible electroporation (IRE) for unresectable renal tumors.
Detailed description
By enrolling patients with renal tumors adapted to enrolled criteria, this study will document for the first time the safety and the short and long term efficacy of percutaneous or intraoperative IRE for renal tumors .
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | irreversible electroporation | Percutaneous (CT-guided and/or US-guided) or open IRE with voltage in level B for renal tumors |
Timeline
- Start date
- 2015-01-01
- Primary completion
- 2020-05-20
- Completion
- 2021-01-01
- First posted
- 2015-01-12
- Last updated
- 2021-09-05
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT02335827. Inclusion in this directory is not an endorsement.